iBio
Tam Phuong has a strong background in scientific research, with recent experience as a Scientist at iBio, Inc. starting in October 2021. Prior to this role, Tam worked as a Postdoctoral Research Fellow at the University of Utah from October 2017 to November 2021, focusing on postdoctoral research. Tam also served as a Postdoctoral Fellow at Moran Eye Institute from May 2014 to October 2017, gaining valuable experience in the field.
Tam Phuong's education history starts in the year 2000 when they attended National University in Hanoi. The details of their degree or field of study during this time are unknown. They then went on to attend Sungkyunkwan University from the years 2005 to 2007, where they pursued a Master of Science (MS) in Environmental Engineering. Finally, Tam Phuong completed their highest degree, a Doctor of Philosophy (Ph.D.) in Physiology from Sungkyunkwan University between the years 2007 and 2013.
This person is not in any offices
iBio
iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It’s FastPharming™ and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce COVID-19 biologics.